Questions discussed in this category
What is your most and least preferred? In case of cancer in remission and in case of non-remission?
There was a recall on viscous lidocaine and many of our patients cannot find it. What would you recommend as alternatives?
Would chemotherapy be preferred over RT?
Does your management change if there is renal involvement of the malignancy?
Patient was previously well controlled on methotrexate, which was discontinued during cancer treatment.
2092520629165681898517739102821454915147139011352712413113669127891087798485
Papers discussed in this category
JAMA network open, 2018-11-02
The journal of allergy and clinical immunology. In practice, 2017
Rheumatology (Oxford),
Rheumatology (Oxford), 2019 Mar 05
Chest, 2021 Feb
J Am Dent Assoc, 2016 Jan 05
The ocular surface, 2015 Jan 15
Arthritis care & research, 2018-10
Am J Med,
Lupus, 2019 Jun 19
Ann Rheum Dis, 2011 Nov 09
Pediatr Blood Cancer, 2021 Oct
JAMA, 2019 Apr 16
Head Neck, 2016 Mar 29
The Lancet. Oncology, 2017-05
Journal of the Endocrine Society, 2022 Dec 02
Diagnostics (Basel, Switzerland), 2021 Apr 20
Arthritis Care Res (Hoboken), 2021 Jul